npj Precision Oncology · 2024 · 493 citations · 122 references
MedicineCancer BiologyOncologyCancer ImmunologyMetastasisTumor MicroenvironmentCancer ImmunotherapyTargeted Cancer TherapyTargeted TherapyTherapeutic ResistanceTumor Immune MicroenvironmentTumor-associated MacrophagesAnticancer Drug ResistanceCancer-associated MacrophagesImmunosuppressive MicroenvironmentTherapeutic Resistance MechanismsTumor Metastasis BiologyTumor Microenvironment HeterogeneityTumor Microenvironment-mediated ResistanceTumor Resistance
Tumor drug resistance emerges from the interaction of two critical factors: tumor cellular heterogeneity and the immunosuppressive nature of the tumor microenvironment (TME). Tumor-associated macrophages (TAMs) constitute essential components of the TME. M2-like TAMs are essential in facilitating tumor metastasis as well as augmenting the drug resistance of tumors. This review encapsulates the mechanisms that M2-like TAMs use to promote tumor drug resistance. We also describe the emerging therapeutic strategies that are currently targeting M2-like TAMs in combination with other antitumor drugs, with some still undergoing clinical trial evaluation. Furthermore, we summarize and analyze various existing approaches for developing novel drugs that target M2-like TAMs to overcome tumor resistance, highlighting how targeting M2-like TAMs can effectively stop tumor growth, metastasis, and overcome tumor drug resistance.
122
SCENIC: single-cell regulatory network inference and clustering
Sara Aibar, Carmen Bravo González‐Blas, Thomas Moerman et al. · Nature Methods · 2017 · 6.9K citations · Full text
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray, Judith E. Allen, Subhra K. Biswas et al. · Immunity · 2014 · 6.2K citations · Full text
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon, Roy L. Maute, Ben W. Dulken et al. · Nature · 2017 · 2.3K citations · Full text
Life Sciences, Immunology, Oncology +16
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda, Karen Messer, Natacha Ralainirina et al. · Nature · 2016 · 1.2K citations